W.G. Shaheen & Associates Dba Whitney & CO Sorrento Therapeutics, Inc. Transaction History

W.G. Shaheen & Associates Dba Whitney & CO

$910 Million
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 07, 2019	SELL	$2.01 - $4.24 $120 - $254	-60 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$4.75 - $8.0 $285 - $480	60 New	60 $0

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.51M

Call Options Held

Put Options Held

B. Riley Securities, Inc. Los Angeles, CA

5.22M
Shares

$1.72 Million
1.01% of portfolio
Swisspartners Ltd. Vaduz, N2

110K
Shares

$36,300
0.12% of portfolio
Kingswood Wealth Advisors, LLC San Diego, CA

65.7K
Shares

$21,664
0.0% of portfolio
Lattice Capital Management, LLC

51.8K
Shares

$17,094
0.01% of portfolio
High Point Advisor Group LLC Downers Grove, IL

22.3K
Shares

$7,342
0.0% of portfolio

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of W.G. Shaheen & Associates Dba Whitney & CO, based on Form 13F filings with the SEC.

News

Stay updated on W.G. Shaheen & Associates Dba Whitney & CO with notifications on news.

Account